Featured Articles
-
Optimizing The Formulation For A Monoclonal Antibody
8/21/2023
An emerging biotech company sought help developing a formulation for a monoclonal antibody. Explore how MilliporeSigma delivered an optimized formulation within an aggressive timeline and budget.
-
Market Watch And Perspectives On Vaccines Manufacturing In APAC
8/16/2023
Nearly forty biopharmaceutical companies, CDMOs, and research institute executives took part in interviews on the future of vaccine manufacturing. Explore the key findings following these interviews.
-
Characterizing AAV Encapsidated Nucleic Acid Sequences Using NGS
8/11/2023
Here, we discuss the characterization of several representative AAV molecules using next-generation sequencing (NGS), including the sequencing process, bioinformatic analysis, and representative results.
-
Maximizing The Value Of Your AAV Using Small Volume AAV Testing
8/11/2023
Learn about MilliporeSigma's approach to method development, where more than one AAV critical quality attribute can be measured within a single analytical run.
-
What The ICH Q5A Virus Safety Guidelines Mean For Your Cell & Gene Therapy Product
8/11/2023
Explore Cell & Gene therapy (CGT) products now within scope of the ICH Q5A guidance, technologies that can replace traditional testing strategies, viral clearance studies expected for vector products, and more.
-
How To Bring Your LNP Formulation To Clinical/Commercial Manufacturing
7/26/2023
To enable the development of next-generation lipid-based drug delivery systems, expertise and manufacturing capabilities are critical.
-
A Comparative Analysis Of Mixing Characterization Methods
7/19/2023
In the bioprocessing industry, there is no single, standard method for measuring mixing performance. Here, we investigate the four most widely used methods for measuring mixing time.
-
Streamlining Viral Vector Development And Gene Therapy Manufacturing
7/19/2023
Explore solutions for gene therapy production from experts, as they highlight the key features of a GMP manufacturing facility, including its technologies and infrastructure, through a virtual tour.
-
Vaccine Journey: Bench To Market
7/19/2023
Vaccines are entering a new era. Gain insight into the market trends, projections, challenges, and potential solutions around the future of vaccine manufacturing.
-
A Molecule’s Journey: Break Down Roadblocks To Clinical Success
7/13/2023
The key to a biopharma executive's success is making the right decisions at the right time. Which will get your biologic to the clinic quickly and cost-effectively, without compromising quality and patient safety?